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Abstract

Intravascular devices with engineered sharps injury protection (ESIP) are
designed to reduce sharps injuries, but have not been investigated for blood splatter
potential. In this laboratory-based experiment, which did not use human subjects, 100
intravenous catheters of the same type with a retraction mechanism, were tested for blood
splatter. Once blood was obtained from a simulated brachial vein containing mock
venous blood, the devices were placed in a testing chamber and scientific filters labeled
A, B & C were used to capture blood splatter after activation. The blood splatter was
examined visually and microscopically, and the filters were weighed pre- and postactivation on an analytical scale. The research questions in this study were: 1) do
retractable intravenous devices produce blood splatter, and 2) does blood splatter
frequency differ between visual methods vs. microscopy?
The differences in filter mass, visual inspection, and microscopic analysis for
presence of blood on filters were the units of analysis. Descriptive statistics, paired t-tests
to determine pre and post activation filter weights and kappa statistics to assess degree of
agreement between methods were used to analyze the data. For filters B and C, the
proportions with blood detected by the naked eye were 12 and 13% respectively.
However, for filter A, both visual and microscopic methods detected blood splatter on
iv
	
  

70% and 71% of the time respectively. In addition, a statistically significant difference
was observed in the mean mass of filter A between pre- and post-activation confirmed by
the naked eye (t= - 0.0013, p= 0.01400) and confirmed microscopically (t= - 0.00014,
p=0.0092). Substantial agreement between methods was observed for filter A
(kappa=0.78; 95% CI: 0.64-0.92), filter B (kappa= 0.73; 95% CI: 0.51-0.95) and filter C
(kappa= 0.75; 95% CI: 0.55-0.96). However, in 7 instances (7%), blood was detected by
microscopy but not by the naked eye on filters A (5 %), B (1%), and C (1%),
respectively. Also, in 6 instances (6%), blood was detected by the naked eye but now by
microscopy on filter B (3%), and filter C (3%). Consequently, there is potential for a total
of 13 % blood splatter.
The findings indicate potential for bloodborne pathogen exposure with use of a
specific retractable intravascular catheter. The finding that blood splatter was detected by
microscopy in 7% of the instances has important occupational health implications.
Healthcare workers (HCWs) may not be able to detect this blood splatter when it occurs
and may not report a splash to mucous membranes or non-intact skin. This study
therefore reinforces the need for HCWs to wear personal protective equipment, such as
masks, face shields, goggles, when using intravascular catheters with retractable
mechanisms. It is recommended that the research protocol used in this study be replicated
by other investigators and tested on all brands of retractable intravascular devices.

v
	
  

Introduction

The quantity and wide range use of devices with engineered sharps injury
protection (ESIP) by all health care workers (HCWs) makes it absolutely necessary to
explore every conceivable approach of potential bloodborne pathogen exposure and
transmission, including the possibility of blood to aerosolize due to activation of safety
mechanism of these devices. The present study was designed to evaluate the safety of
retractable intravascular devices in terms of their potential to produce blood splatter.

Risk to Health Care Workers
In the last few decades, multiple diseases due to bloodborne pathogens have
emerged bearing serious effects on infected persons who come in contact with infected
blood (blood of person with the disease). One group at a high risk for exposure is the
health care worker (HCW). HCWs, due to the nature of their occupation, are in constant
contact with patients’ blood and other body fluids. Consequently, they have been
identified to be at high-risk for bloodborne pathogen exposure, transmission, and
infection from hepatitis B virus (HBV), hepatitis C virus (HCV), and human
immunodeficiency virus (HIV). It is estimated that 385,000 cases of occupational
exposure to bloodborne pathogens from needlestick and sharps injuries are reported
annually for hospital based healthcare workers (CDC-Sharps Safety 2010, and Panlilio,
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et. al. 2004). Furthermore, after a needlestick injury (NSI), the risk of infection ranges
from 6% to 30% for HBV, 1.0% to 10.0% for HCV with an average of 1.8% , and an
average of 0.3% per percutaneous injury for HIV (CDC-NIOSH 2000). Also, the risk for
HIV infection after an exposure to mucous membranes is estimated to be around 0.09%
(CDC-NIOSH 2000). In addition to the above mentioned viruses, more than 20 other
bloodborne pathogens can be transmitted via NSI (CDC-Sharps Safety 2010).

History of Regulations
In the era when devices were not designed with engineered sharps injury
protection (ESIPs), NSIs were a major cause of health care worker exposures to
bloodborne pathogens (CDC-NIOSH 2000). To protect HCWs from bloodborne
pathogens due to NSIs, the Centers for Disease Control and Prevention (CDC) published
a list of recommended Universal Precautions in 1987 (CDC 1987). Later on, in
November of 2000, the US congress passed the Needlestick Safety & Prevention Act
(NSPA, House of Representatives, and CDC-NIOSH 2000). This was followed by the
subsequent 2001 revision of the Occupational Safety and Health Administration’s
(OSHA) Bloodborne Pathogens Standard (BPS). The OSHA BPS requires employers to
provide devices with ESIP for all HCWs, and their use has significantly reduced the risk
of NSIs (Panlilio, et. al. 2004). Prior to the implementation of the state and federal laws
for the use these safety devices, just 15% of US hospitals were practicing with this type
of the devices (Foley & Leyden 2005). Since the Needlestick Safety & Prevention Act,
commercial ESIP devices were brought to the market with the aim of reducing the risk of
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NSIs to HCWs. One of these of devices is an intravenous catheter with a retractable
mechanism, with one specific brand being tested in this study.

Research on Exposure to Blood Splatter
Criteria used for the evaluation of ESIP devices efficacy include minimization of
both the incidence of NSIs and the exposure/transmission of bloodborne pathogens to
HCWs (Foley & Leyden 2005, and Haiduven, et. al. 2009). However, even though ESIP
devices may protect from needlestick injuries, they may not protect from exposure to
bloodborne pathogens. The safety activation of the device may cause blood splatter,
which is the microaerosolization of blood (Haiduven, et.al. 2009). Taylor (1990)
indicated that mucous membranes of the face and none-intact skin are potential portals
for transmission of bloodborne pathogen from miniscule amounts of infected blood. In 17
out of 20 cases the blood splatter occurred and in some cases, the amounts were invisible
to the naked eye. This suggests that any amount of blood splatter can pose a potential
health risk and more importantly if it occurs in aerosol form.
Review of the studies on health care workers and the use of devices with ESIP
indicate that blood splatter does occur when ESIP devices are activated, and the mucus
membranes and non-intact skin are potential paths of transmission. As a result, some
HCWs have contracted bloodborne pathogens while using these devices.
A study of 43 HCW exposed to bloodborne pathogens conducted in Poland from
2001 to 2004 found that HCWs were exposed to HBV, HCV, and HIV. Thirty-four (34)
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of these injuries were by needlestick, and four (4) cases due to splash on the skin and
conjunctiva, while performing procedures. The rest of the injuries were due to other types
of sharp. This study indicated that from all these cases one HCW was treated for HBV
and four (4) were being observed due to HCV (Dancewicz, et.al. 2005).
A report from Australia, based on research carried out from 1998-2003
retrospectively, indicates 931 HCWs out of 2200 HCWs were exposed to blood and body
fluid. The study found that sharp injuries and activation of safety intravascular devices
resulted in 594 of percutaneous and 337 mucocutaneous cases of exposed HCWs to blood
and body fluid splatter (Bi, et.al, 2006). Another study from Turkey indicated that HCWs
exposed to blood splatter on their conjunctiva from infected patients with HCV were at
risk for developing the disease (Hosoglu et.al, 2003). This study mentioned one
confirmed case of infection with HCV due to blood splatter to the mucous membranes
during in a hemodialysis unit. Wines et. al. (2008) also indicated that mucocutaneous and
transconjunctival exposure remains as routs for the transmission of bloodborne pathogens
to HCWs. The study that included 118 cases indicated that a modern forensic method was
used to detect blood splash not visible by the naked eye during procedures performed by
the HCWs. The study found evidence of positive blood splash in 84.2% even in video
laparoscopic procedures. Furthermore, this study recommends use of personal protective
equipment (PPE) by all HCWs while performing procedures in all healthcare sittings.
Based on anecdotal reports from HCWs in the field and the potential risk of blood
exposure from intravascular devices with retractable mechanisms, Haiduven, et.al (2009)
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designed a laboratory study to evaluate the potential of blood splatter. They conducted
pilot testing of several different devices in order to develop methods for the measurement
of blood splatter. More specifically, they studied three types of retractable intravascular
devices: two phlebotomy devices (a vacuum tube device and a winged butterfly device)
and a retractable IV catheter with a retractable mechanism. They tested one hundred of
each of the devices using an injectable extended antecubital fossa (ACF) pad attached to
a blood bag containing mock venous blood. They used filters to collect the blood splatter
when the devices were activated. They found a significant difference in the weight of the
filters before and after activation for the IV catheter and the winged butterfly set due to
blood splatter. Results for the vacuum tube device were equivocal.
A recent report from England (Ford & Phillips, 2011) found that when three
different intravascular devices with safety mechanisms were tested [two with needle
shields Eclipse (Becton Dickinson), and Quick Shield (Greiner Bio-One)] and one with a
retractable needle [Push Button (Becton Dickinson)] used for blood evacuation), the
HCWs in the study reported blood splatter. The researchers then tested simulated blood
with the same devices (twenty of each type) and placed a colored paper underneath the
device. The researchers confirmed via an ultraviolet light that there was blood splatter in
areas close to the activation of the safety system. The author confirmed that all 3 types of
devices caused blood splatter on activation. The study reported that the frequency of
blood droplets from Eclipse was eight out of 20 (40%), 2 out of 20 for Quick Shield
(10%), and for the Push Button, the frequency was 7 out of 20 (35%). These laboratory
studies confirm that there is a potential for occupational exposure to bloodborne
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pathogens for the HCW associated with the activation of intravascular devices with
retraction mechanisms that were originally designed to avoid needlestick injuries. These
results support the need for the use of personal protective equipment to protect the
mucous membranes and skin of HCWs when they are performing intravascular
procedures with such devices.

Hypotheses
To build on the work of Haiduven, et.al. (2009), the present study investigated a
different type of automatic retractable intravascular device (the Becton Dickinson Insyte
Autoguard). An activation assembly chamber was designed for this experiment in a
attempt to capture of all possible blood splatter onto several filters located in the
immediate vicinity. The study tested not only the difference in filter weight before and
after activation of the retraction mechanism on the device in order to confirm the
previous results, but also compared the visibility of blood splatter by the naked eye vs.
microscopic examination using Cohen's kappa statistics that measures the degree of
agreement between categorical judgments (i.e., “yes” vs. “no”).
A review of the literature yielded no results on other studies that used the
microscope as an instrument to detect blood splatter from the activation of retractable
safety mechanisms. Nonetheless, the microscope has been an innovative and useful tool
for bloodstain pattern analysis during criminal investigation when it is necessary to use
small stains that are difficult to measure. A study by Valkiūnas et al. (2008) compared
parasitic prevalence information obtained by both microscopy and polymerase chain
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reaction and showed that both methods yielded similar results, reinforcing the notion that
microscopy is a reliable tool that is relatively inexpensive, provides valuable information,
and is unlikely to result in false positives. In this study, the microscopic examination was
being used to demonstrate that there is blood splatter even when the HCW cannot
perceive its presence.
The research questions in this study were: 1) do retractable intravascular devices
produce measurable blood splatter; and 2) does blood splatter frequency differ between
visual methods vs. microscopy? The hypotheses were: 1) there will be a significant
difference in the mean mass of the filters used to detect blood splatter at three different
locations before and after activation of the intravascular device; and 2) the presence of
blood splatter on the filters can be seen by microscopic examination even if not visible to
the naked eye.
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Research Methods
In this section, the following will be presented: an overview of the research
methods in this study, a description of the testing materials and how they were used, an
explanation of the testing protocol, a description of the data collected and the statistical
analyses performed.

Methods Overview
In this experiment, which did not use human subjects, 105 intravenous catheters
with a retraction mechanism were tested for blood splatter. The experiment was
conducted in a controlled laboratory environment designed to simulate the environment
of the health care setting. The study was performed inside two separate tissue culture
hoods, which provided a controlled environment free from contamination and any sudden
changes in airflow.
Injectable extended antecubital fossa (ACF) pads that simulate the human brachial
vein were attached to a mock venous blood bag consistently containing 500 ml and
infusion tubing. The retractable intravascular device being tested was inserted into an
injection site in the ACF pad to simulate and serve the purposes of use in humans in
healthcare sittings. After insertion, each retractable device was placed in a testing
chamber and activated. Scientific filters were placed in the activation chamber and used
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to capture blood spatter after activation. For identification purposes, the three filters were
denoted as Filter A, Filter B, and Filter C based on their location and use at different
points of the activation chamber. Filter A was located inside the activation chamber’s
cylinder, to capture splatter from around the activation mechanism, Filter B was located
anterior to the device to capture splatter from the tip of the needle, and Filter C was used
to wipe the device, the researcher’s gloves, and the back section after device activation.
The weights of the three scientific filters used for each retractable intravascular
device were measured pre- and post-activation by an analytical scale and recorded on a
spreadsheet. Before recording any weights, it was ensured that the scale was zeroed with
the specimen receptacle attached. All filters were visually and microscopically inspected
pre-activation for the integrity of the filter and the presence of foreign materials, and
post-activation for the presence of visible blood. Digital microscopic photographs were
taken of any visible blood. Findings were recorded for each of the parameters as a
dichotomous outcome (“Y” [Yes] was assigned to denote the detection of visible blood,
and “N” [No] where blood was not detected.). The presence or absence of mock venous
blood by either the naked eye or the microscopic examination of each of the filters, and
the difference in filter mass before and after device activation, were the primary units of
analysis for detecting blood splatter. Data were recorded on an EXCEL spreadsheet and
triple data checking was performed to record each measurement.
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Retractable Intravascular Device
In this study, 105 retractable intravascular devices were tested. The retractable
intravascular safety device that was tested was Becton Dickinson’s Insyte Autoguard,
with a 2 0 gauge 1.1 X 25mm needle, and an automated mechanism that, when activated,
rapidly retracts the needle into its barrel, as shown in Figure 1.

Figure 1. Retractable intravascular device (Becton Dickinson, 2011). Retrieved from
http://www.vitalitymedical.com/intravenous-shielded-catheter-infusion-sets-insyteautoguard-by-bd-becton-dickinson.html

The specific protocol developed for this study was based on the retraction
mechanism, its activation, and the manufacturer’s instructions for use. Activation was
defined as the motion resulting in retraction of the needle itself from its own plastic
cannula into the barrel of the device as seen in Figure 1 (device post activation).
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Antecubital Fossa (ACF) Pad and Mock Venous Blood
Two injectable extended antecubital fossa (ACF) pads (a soft tissue pad that
simulates the antecubital fossa of the human’s right arm and was used for venipuncture
and the introduction of cannulae; Limbs & Things, Bristol, UK) were attached to a blood
bag containing mock venous blood and infusion tubing as displayed in Figure 2.

	
  

Figure 2. ACF pad in the tissue culture hood.
Note: Pad is attached to a mock venous blood bag (left upper corner) and infusion tubing.
The mock venous blood used in this experiment, was an artificial blood simulant
with the same color and viscosity of human venous blood. Two intravenous catheters
	
  
11	
  
	
  

were inserted into the ACF pad. One catheter was inserted into the top portion of the pad
(blood entrance site) and the other catheter was inserted into the distal end of the venous
system of the ACF pad (venous blood exit site). The injection pad was supplied with a
continuous flow of mock venous blood from a 500 mL supply bag connected to the
catheter at the proximal end via intravenous tubing with an on/off flow clamp. The
supply of blood was monitored and adjusted as necessary in order to keep the volume
between 400-500 mL. The catheter at the distal end was connected to an empty supply
bag to maintain a continuous flow system and served as a collection system for the mock
venous blood as it exited the ACF pad. The amount of mock venous blood that moved
into the device on each insertion was not measured. For this experiment a total of 15
mock venous blood bottles (250 ml each) were used.
As shown in Figure 3, each ACF pad was pre-marked and numbered with 50
insertion sites (1-50 and 51-100, respectively; an additional 5 sites were tested on a third
pad). A sequence pattern was established so that the insertion sites into the 3 simulated
veins were not consecutively placed. Each new insertion site was not adjacent to the
previous insertion site; rather the sites rotated in location, as shown in Figure 4. However,
each of the ACF pads was pre-marked with the same pattern to minimize the threat of
misclassification.
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Figure 3. ACF pad pre-marked and numbered for each insertion site.
Note: This is a smart site infusion set from Cardinal Health, with continuous blood source
and receptacle for the artificial blood.
An absorbent pad (cotton on one side and plastic on the other) was placed on the
ACF pad above and below each insertion site to provide additional protection and prevent
any seepage that could occur. Stomahesive tape was used to cover each insertion site
after the device and the number were removed from the previous numbered insertion site
of the ACF pad. The reasons for this were: 1) to prevent excess seepage from the
insertion site, and 2) to avoid entering the same insertion site twice.
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Figure 4. Close up view of the insertion sites on the ACF pad.

Activation Chamber
The

terms

“Activation

Chamber

or

Assembly

Chamber”

were

used

interchangeably to represent a custom-designed apparatus to hold the retractable
intravascular device for the purpose of device activation, the detection of blood splatter at
the activation site and the immediate vicinity. “Activation Chamber” was used to collect
any blood splatter resulting from activation of the device after the catheter was removed
from the ACF pad but before the needle was retracted into its barrel, as shown in Figure
5.
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A

Figure 5. Retractable intravascular device positioned in activation chamber

Scientific Filters
Over three hundred scientific filters composed of Kimberly Clark heavy duty
coverall particulate arrester material, tested at greater than 0.3 microns, pre-labeled 1-X,
were used to capture blood splatter from the retracting devices positioned at different
points inside of the activating chamber. The scientific filters were designated filter A,
filter B, and filter C. Filter A was positioned inside and around the activation chamber’s
cylinder and filter B was positioned anterior to the retractable intravascular device (see
Figure 6). Filter C was used to wipe the back section of the chamber, the glove, and the
outside of the intravascular device.
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a.

b.
Figure 6. Filters A and B in the assembly chamber.
Note: Filter A is shown in a) and filter B is shown in b).
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Analytical Scale
As illustrated in Figure 7, an Ohaus Adventure Pro Analytical Scale calibrated to
1/1000g was used to weigh the filters before and after activation of each device. The
experiment was conducted inside a tissue culture hood, which provided a controlled
environment free from contamination and any sudden changes in airflow. A prevalidation protocol was performed to determine the reliability of the scale. The weights of
the three scientific filters used for each retractable intravascular device were measured in
milligrams on the analytical scale and recorded on an Excel spreadsheet.

Figure 7. Ohaus adventure pro analytical scale in tissue culture hood.
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Digital Microscope
For this experiment a stereoscopic microscope with digital camera (Model DC5420TH 10x-40x magnification, National Optical & Scientific Instruments, San Antonio,
Texas; with digital camera: software Motic Image Plus Version 2.0, Richmond, British
Columbia V6V 2K9 Canada) was used. The filters were divided into 9 areas that allowed
the viewer to provide a more specific location when describing any material seen during
the microscopic inspection of the filter as shown in Figure 8 (Areas of the Filter).

Filter number
identification here
herelabel here

Figure 8: Division and labeling of nine areas of the filter.
Note: The presence of blood was examined for each area in the microscopic review.
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All the filters were perused with the low power objective (10x) using the pattern
shown on Figure 9 (a diagram of how to scan the filters pre and post device activation).
This allows for overlapping of the fields when looking under the microscope, reducing
the chances of missing an area of the filter. Any suspicious material was further
examined using the high power objective (40x), and results were recorded in a worksheet
by the research team using triple data checking.
Start Point

End point

Figure 9. Diagram of filter scans pre and post device activation.

Blood splatter was photographed with the microscope’s digital camera, with some
examples shown in Figure 10. The digital pictures were labeled with the filter
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identification number, and stored in a computer file that could be accessed for future
references.

a.

b.
Figure 10. Filters with blood splatter.
Note: Photos a) and b) were photographed with the microscope’s digital camera.
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Testing Protocol
Four researchers (R1, R2, R3, and R4) conducted the testing protocol. The
researchers included an occupational health resident physician for device insertion and
activation (R2), biomedical engineer assistant for analytical scale measurement and
passing of filters (R1), a medical microbiology technician to examine scientific filters
under the microscope (R4), and an infection prevention and occupational health expert
who timed the experiment and recorded the data (R3). R1 worked primarily inside the
tissue culture hood number one with the scale and the filters, while R2 worked inside
tissue culture hood number two to insert and retract the device, and to activate the device
in the activation chamber located next to the second tissue culture hood. R1 did all of the
scale readings. R3 opened the I.V. mock blood flow system, monitored R1 & R2’s
activities, connected the IV needle to a luer-lock syringe, operated the timer, called the
steps, recorded data, opened and closed the clamps of the IV tubing, and carried the
filters to R4. R4 examined the filters under the microscope pre-activation weighing for
any artifacts and then post-activation weighing for the presence or absence of blood. R1
used bent forceps to place filters on and off the scale and to hand filter “C” to R2. R1
used straight forceps to place used filters into microscopy storage bins. R4 used forceps
to handle all filters.
A 111-step protocol was developed by the research team. The sections of the
protocol were as follows: pre-trial activities; initial filter weights; device preparation,
insertion & activation; filter visual inspection, weighing, and microscopic inspection; and
post-trial activities. In order to collect data for 105 trials (5 trials were excluded but a
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total of 100 were needed, thus the reason for sequencing up to 105), the steps were
followed 105 times.
Before beginning of the experiment each day, each tissue culture hood surface
and the activation chamber were cleaned out thoroughly. All equipment and supplies
(filters, syringe materials, scale, injection pad, sharps collection receptacle, sharps
container and cleaning wipes) were placed inside the work area. Once the work areas and
inside the tissue culture hoods were completely stocked, the adjustable shield was moved
to the lowest possible position that allowed R1 and R2 to place both of their arms into the
work area and to conduct the experiment. All researchers donned lab coats and clean
gloves.

Pre-Trial Activities
The analytical scale was zeroed with the attached specimen receptacle, the blood
bags were checked to ensure 500 cc levels were maintained; sites of insertions were
prepared and protected from potential contamination.

Initial Filter Weights
R1 removed appropriately the numbered filters from the unused filter storage bin
in order (filters A, B, and C). R1 placed each filter on the scale with the numbered, non-
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absorbent side down; then called out the weight as read off the scale and repeated the
number for verification. In this set of steps, all the filters were handled with a forceps.

Device Preparation, Insertion and Activation
The company’s instruction for the use of the device and insertion into the vein
were followed by R2. After inserting one of the devices into a pre-marked site, blood
return was observed, and the needle removed from the designated vein location on the
ACF pad without activating the retraction mechanism. The device was then positioned in
the activation chamber and the safety mechanism activated.

Filter Visual Inspection, Weighing, and Microscopic Inspection
R2 thoroughly examined the fingers, palm and back of the inner pair of the gloves
on the right hand; filter A ; filter B; filter C, and the back section of the device holder for
the presence or absence of visible blood and was recorded after verification by R4. The
scale was zeroed each time prior to weighing each filter by R1. All the filters were
thoroughly examined under the microscope and the presence and the absence of blood
were recorded. Filters with the presences of blood were photographed by R3.
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Post-Trial Activities
Once all of the filters were examined, each filter was placed in a designated
temporary container labeled for each filter (A, B, and C). In this period the instruments
used were cleaned, in preparation for the next trial.

Post-Experiment Activities
After each 10th time, the balance on the scale was checked and gloves were
changed. At the end of the day, used filters were placed into storage containers labeled
separately for “A”, “B”, & “C”.

Statistical Analyses
The data set encompassed a total of 105 experimental trials on one specific design
of a retractable intravascular device. Data from five trials were excluded to prevent any
compromise to the validity, leaving a total of 100 trials were retained for the final
analysis. The difference in mass of filters A, B, and C (the mass of the filter postactivation minus the mass of the filter pre-activation) were computed to determine
whether a change in weight occurred. To determine whether or not the observed mean
difference was due to blood splatter or merely due to chance, a paired sample t-test was
conducted to compare the mean weight of each filter pre- and post-activation.
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Furthermore, the data for detected blood on all of the filters was compared for
visible blood detected by the naked eye and by the microscope. Because two different
methods for detecting the presence of blood were utilized, it was necessary to measure
the magnitude of agreement between the two methods of blood detection for each of the
300 filters. To determine whether the agreement can be attributed to chance findings, a
kappa statistic (Landis & Koch, 1997) was calculated to compare the degree of agreement
between filter examination results with the naked eye versus microscopy with respect to
the presence of blood for each filter. Tests of hypothesis were two-tailed with a type I
error rate fixed at 5 percent. SAS version 9.1 (SAS Institute, Cary, NC) was used to
perform all analyses.
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Results

The research questions in this study were: 1) do retractable intravascular devices
produce measurable blood splatter; and 2) does blood splatter frequency differ between
visual methods vs. microscopy? The hypotheses are: 1) there will be a significant
difference in the mean mass of the filters used to detect blood splatter at three different
locations before and after activation of the intravascular device; and 2) the presence of
blood splatter on the filters can be observed by microscopic examination even if not
visible by the naked eye.

Table 1. Frequency and percentage of filters A, B, & C with blood by visible detection
and microscopic methods based on 100 trials.

Frequency
Percent (%)

Visible Blood by Naked
Eye
Filter A Filter Filter
B
C
70
12
13
70.00

12.00

13.00

71.00

9.00

10

Cumulative Freq

100

100

100

100

100

100

Cumulative Percent
(%)

100

100

100

100

100

100
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Visible Blood by
Microscopy
Filter A Filter Filter C
B
71
9
10

Table 1 shows that the proportion of filters with detectable blood examined by the
naked eye were 70%, 12%, and 13% for filters “A”, “B” and “C” respectively, while
examination by microscopy showed that the proportion of filters with detectable blood
were 71%, 9%, and 10% respectively. Compared to filter “A,” a smaller proportion of
filters “B” and “C” contained detectable blood. Thus, the filter with the highest
proportion of detected blood using both methods of detection, as compared to the
remaining filters (B and C), was filter A. Figure 1 illustrates the proportion of filters with
detected blood through microscopic vs. naked eye examination, for filters A, B & C
respectively.
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Figure 11. Proportion of filters A, B, and C with detected blood.
Note: This compares the filters with blood detected by visual vs. microscopic methods.
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A paired student t-test was used to compute the mean (± standard error) mass
difference for filters A, B, and C before and after activation. The analysis of the mass
difference for each filter included only those observations where blood was detected on
the specified filter by the naked eye or microscopically. Table 2 illustrates the mean
differences for each filter type by detection method. The results indicate that there was
negative mass difference for some of filters for both detection methods.

Table 2. Mean mass difference, standard deviation, and confidence intervals by filter
type and detection method
	
  

Visible Blood by Naked Eye	
  
Filter A
Filter B
Filter C
N

70

12

13

Visible Blood by Microscopy	
  
Filter A	
   Filter B	
   Filter C
71

9

10

MD

-0.00013 0.000025 0.000115 -0.00014 0.000156 0.000200

SD

0.000431 0.000569 0.000580 0.000447 0.000525 0.000643

95% CI

-0.00023 -0.00034 -0.00024 -0.00025 -0.00025 -0.00026
-0.00003 0.000387 0.000466 -0.00004 0.000559 0.000660

Note: N= number of trials with blood splatter, MD= mean mass difference, SD=
standard deviation, SE= standard error, CI= confidence interval

The statistical significance [p < .05] of the mean mass difference is shown in
Table 3. Results indicate that the difference between the mean mass of filter A preactivation and mean mass post-activation was statistically significant for the proportion
of filters with detected blood by the naked eye [t= - 0.0013, p= 0.0140] and
microscopically [t=- 0.00014, p= 0.0092]. However, there was no statistically significant
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difference between the mean mass of filters B and C pre- and post-activation for either
detection method.

Table 3. Mean mass differences and significance values by filter type and detection
method
Filter A ≠
MD [p-value]

Filter B≠
MD [p-value]

Filter C≠
MD [p-value]

Naked Eye*

-0.0013
[0.0140]

0.00003
[0.8818]

0.0012
[0.4869]

Microscopy*

-0.00014
[0.0092]

0.00156
[0.3997]

0.0002
[0.3509]

Note: MD = Mean mass difference
Mean mass difference of specified filters as assessed by t-test, p<0.05
*
Analysis of the mean mass difference for each filter was conducted including only
those observations where blood was detected on the specified filter.

≠

The second research question was whether there was a difference in visible blood
detection by the naked eye vs. microscopic examination. Table 4 shows the percentage of
agreement between these two methods of detection. The associated frequency data for
filter A shows that in 66 out of 70 times there was agreement that visible blood was
present, and 25 out of 30 times there was agreement that visible blood was not present.
The frequency data for filters B and C shows similar agreement on the presence of visible
blood (8 out of 12 and 9 out of 13, respectively) and on the absence of visible blood (87
out of 88, and 86 out of 87, respectively).
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Table 4. Percentage and frequency of agreement on presence or absence of visible blood
for filters A, B & C
Filter Type

Presence [Freq]

Absence [Freq]

Filter A

94 [66/70]

83 [25/30]

Filter B

67 [8/12]

99 [87/88]

Filter C

69 [9/13]

99 [86/87]

Note: [Freq] = frequency

To determine whether the degree of agreement on the presence or absence of
visible blood between the two methods of examination was significant, a kappa test was
performed. A statistically significant kappa indicates that the agreement is better than
chance. Based on a commonly cited scale, where the possible values range from 0 to 1.0,
0 equals no agreement and 1.0 indicates perfect agreement. The relationship between the
statistic and level of agreement is presented in Table 5.

Table 5. Interpretation of the kappa statistic
Kappa
Kappa
<0
0.01-0.20
0.21-0.40
0.41-0.60
0.61-0.80
0.81-0.99

Poor

Slight

Fair

Moderate

Substantial

0.0

0.20

0.40

0.60

0.80

Agreement
Less than chance agreement
Slight agreement
Fair agreement
Moderate agreement
Substantial agreement
Almost perfect agreement
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Perfect
1.0

Table 6. Kappa statistic on agreement between methods of blood detection on filters A,
B, & C

Filter Type

Kappa [95% CI]

Filter A

.78 [0.65-0.92]

Filter B

.73 [0.51-0.96]

Filter C

.75 [0.55-0.96]

The kappa results for this study are summarized in Table 6. Assessing agreement
between the two detection methods for the presence of visible blood resulted in a kappa
statistic of 0.78 [95% CI 0.65-0.92] for filter A, 0.73 [95% CI: 0.51-0.96] for filter B, and
0.75 [95% CI 0.55-0.96] for filter C. These results show that there is substantial
agreement between detection methods regarding the presence or absence of visible blood
for each of the filter types. Furthermore, the confidence intervals show that the degree of
agreement was statistically significant.
Despite the overall agreement on the presence of visible blood between methods
of detection, there were trials that demonstrated that the human eye is not capable of
detecting all blood splatter. Table 7 provides a comparison of the trials in which there
was disagreement between the methods of detection. Seven trials did not have visible
blood detected by the naked eye, but showed evidence of blood splatter under the
microscope. For filter A, there were five trials where blood was detected solely by the
microscopic examination, while for filters B and C there was one trial each where blood
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was detected by microscopic examination. Thus, these results indicate that seven percent
(7%) of the trials exhibited blood microscopically that was not visible to the naked eye.

Table 7. Comparison of trials showing the presence of visual blood via microscopic
examination but not the naked eye
Filter A
Trial
Number

Naked
Eye
N
N
N
N
N
N
N
0

Micros
copy
Y
N
Y
Y
Y
Y
N
5

Filter B
Naked
Eye
N
N
N
N
N
N
N
0

Micros
copy
N
Y
N
N
N
N
N
1

Filter C
Naked
Eye
N
N
N
N
N
N
N
0

Micros
copy
N
N
N
N
N
N
Y
1

6
7
16
53
55
72
102
Total
105#
Note: Y= presence of blood, N= no presence of blood. One hundred and five trials were
completed but five were eliminated due to factors compromising the validity.
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Discussion

HCWs have been identified to be at high-risk for bloodborne pathogen exposure,
transmission, and infection from HBV, HCV, and HIV. The results in this study are
consistent with previous research on such exposures. Several studies have evaluated
intravascular devices in relation to potential blood splatter to face and mucus membranes
(Ford & Phillips, 2011; Haiduven et.al, 2009). Taylor (1990) found that mucous
membranes are potential routes of transmission from miniscule amounts of infected blood.
In some cases, the amounts were invisible to the naked eye. This suggests that any amount
of blood splatter can pose a potential health risk, especially if it were to become
aerosolized. In this study, the scientific filters captured blood splatter that was not
noticeable by the naked eye but was detected by microscopy in 7% of the instances. In
another 6% of instances, blood visible to the eye was not evident by microscopy and may
have been explained by small fibers falling off of the filter in between visual examination
and microscopic examination. Therefore, a potential of 13 /100 times, blood splatter might
have occurred to HCWs who may not have been aware of the exposure. HCWs may not be
able to detect the blood splatter when it occurs and may not report a splash to mucous
membranes or non-intact skin.	
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Prior research has confirmed that HCWs are the one group with the highest risk
for bloodborne pathogen infection after exposure by NSIs. The risk of infection ranges
from 6% to 30% for HBV, 1.0% to 10.0% for HCV (with an average of 1.8%), and an
average of 0.3% per percutaneous injury for HIV (CDC-NIOSH 2000). Also, the risk for
HIV infection after an exposure to mucous membranes is estimated to be around 0.09%
(CDC, 2010). Because of this risk, it is necessary to reinforce the need for HCWs to wear
personal protective equipment, such as masks, face shields, and goggles, when using
retractable intravascular devices to prevent exposure, transmission, and infection by
bloodborne pathogens. Furthermore, this study reinforces the need for redesign of the
device in order to eliminate the potential for blood splatter and exposure of HCWs to
bloodborne pathogens.
This study has multiple strengths. First, the presence/absence of blood splatter on
the filters was confirmed by examination of all filters pre and post activation of the
intravascular device by a high powered microscope (equipped with digital camera), which
enhanced validity of the study. This eliminated the potential presence of confounders on
each filter. Second, the entire experiment was performed under a tightly controlled
environment to prevent changes in temperature and air flow. Third, once the protocol was
finalized, it was adhered to strictly in each trial to ensure standardization and strengthen
internal validity. Fourth, the sample size was greater than for many other studies testing
blood splatter by retractable intravascular devices. Fifth, a single health care physician
conducted all the intravascular device insertions in the ACF pad, therefore, eliminating
variation. Sixth, the entire experiment (material and methods) process was designed to
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resemble the conditions in a health care facility. Finally, the researcher group included a
multi- disciplinary team: an MD, a RN- PhD in occupational health, a biomedical engineer
assistant, a medical microbiology technician, and an MD, PhD in biostatistics.
This study has a few limitations. First, and probably the most important one, is
that it was not conducted on human subjects. For humans, device activation would occur
while the needle is in the vein, whereas in this study, device activation occurred away
from the site of insertion. The transportation of the device may have resulted in a loss of
blood droplets. Second, the class of filters used for this experiment to capture blood
splatter had a large amount of thin fibers on the surface of the filters. The results indicated
that there was a negative mean mass difference for filter A. The negative mass difference
might be attributed to several factors. One of these factors is the potential loss of thin
fibers from the filters during the process of wiping, transporting, and examining the filters.
Another possible factor is a loss of moisture from the filters during the time period
between pre and post activation of the device. The blood on the fibers of the filters could
fall off from the filter due to the thin surface fibers. For these reasons, this study has
expanded the previous work of Haiduven et al. (2009), in the area of no longer using
change in mean mass filter weight as a parameter. Rather, the microscope should be used
to examine the filters. Finally, the protocol did not include a standardized method for
describing or characterizing the patterns of blood splatter.
The results of this study provide several implications for future research. Future
studies could investigate the direction, location, and distance of blood splatter. High-speed
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photography might be used to represent the motion and location of blood splatter at the
moment of device activation. This protocol could be replicated by other investigators and
tested on all brands of retractable devices. Research on human subjects could provide
information on how device activation affects blood splatter in humans, and whether
personal protective equipment can eliminate exposure. Furthermore, research could be
done on potential methods for redesigning ESIP devices to completely eliminate blood
splatter.
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